The causes of death among patients with tuberculosis Source: International Congress 2015 – Epidemiology of TB: deaths, co-morbidities, migration and children Year: 2015
The top of the iceberg - Extensively drug resistant tuberculosis (XDR-TB) in 2010 Source: International Congress 2015 – Epidemiology of TB: deaths, co-morbidities, migration and children Year: 2015
Delay in pulmonary tuberculosis treatment in Croatia Source: Annual Congress 2013 –Treatment and adherence to treatment of respiratory disease Year: 2013
Is there a need for prolonged follow up in mono-drug resistant TB? Source: International Congress 2014 – Tuberculosis: epidemiology and public health Year: 2014
Characteristics of tuberculosis (TB) in patients that died from TB in Poland Source: International Congress 2016 – Epidemiological insights into tuberculosis pathogenesis Year: 2016
The global response to rifampicin-resistant tuberculosis: Current situation and recent trends Source: International Congress 2016 – Rifampicin resistance, MDRTB, and new drug treatments Year: 2016
The cost of tuberculosis in Denmark Source: Annual Congress 2013 –Epidemiological and public health features of tuberculosis Year: 2013
Knowledge and attitude about tuberculosis disease in a health workers population Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management I Year: 2013
Impact and management of TB childhood outbreaks in EU/EEA Source: Annual Congress 2013 –Epidemiological and public health features of tuberculosis Year: 2013
Factors associated with pulmonary tuberculosis treatment outcome in Kocaeli; Turkey Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1 Year: 2014
Tuberculosis in Bucharest continues to be a concern Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management I Year: 2013
Multidrug-resistant and extensively drug resistance tuberculosis has a strong public health and economical impact in the Republic of Moldova Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection in subpopulations Year: 2013
Estimating costs for treating patients with multi-drug resistant tuberculosis (MDR TB) under the regional tuberculosis control program, Tomsk (Russia) Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes Year: 2015
The health economics of treating MDR-TB in the Indian private sector Source: International Congress 2016 – How the increasing complexity of chronic care management challenges ethics and costs in our healthcare system Year: 2016
MDR TB treatment results of GFATM program implementation in Tomsk, Russia Source: International Congress 2015 – Management of TB: a patient focus Year: 2015
Tuberculosis (TB) and young age Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1 Year: 2014
Knowledge and practices of hospital employees on tuberculosis Source: Annual Congress 2013 –Tuberculosis: clinical epidemiology and public health Year: 2013
Tuberculosis and HIV infection in combination with multidrug resistant MBT on Northwest of Russia Source: International Congress 2016 – Epidemiological aspects of tuberculosis and other respiratory conditions: from lung cancer to late-onset Pompe's disease Year: 2016
Risk factors for anti-TB drug resistance in Poland Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management III Year: 2013
Transmission pattern of MDR-TB in Singapore 2005-2015 Source: International Congress 2016 – Rifampicin resistance, MDRTB, and new drug treatments Year: 2016